172 related articles for article (PubMed ID: 22304770)
1. [The mechanism of polypeptide derived from viral macrophage inflammatory protein II modulates SDF-1α/CXCR4-induced migration].
Yang QL; Ding YX; Chen CJ; Yang ZF; Gao YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):137-40. PubMed ID: 22304770
[TBL] [Abstract][Full Text] [Related]
2. Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II.
Yang Q; Chen C; Yang Z; Gao Y; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):497. PubMed ID: 21823011
[TBL] [Abstract][Full Text] [Related]
3. Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs).
Sameermahmood Z; Balasubramanyam M; Saravanan T; Rema M
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3305-11. PubMed ID: 18660423
[TBL] [Abstract][Full Text] [Related]
4. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization.
Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J
Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202
[TBL] [Abstract][Full Text] [Related]
5. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells.
Peng SB; Peek V; Zhai Y; Paul DC; Lou Q; Xia X; Eessalu T; Kohn W; Tang S
Mol Cancer Res; 2005 Apr; 3(4):227-36. PubMed ID: 15831676
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
7. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
11. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer.
Yang Q; Zhang F; Ding Y; Huang J; Chen S; Wu Q; Wang Z; Wang Z; Chen C
Br J Cancer; 2014 Mar; 110(5):1288-97. PubMed ID: 24448360
[TBL] [Abstract][Full Text] [Related]
12. Chemokine stromal cell-derived factor 1alpha activates basophils by means of CXCR4.
Jinquan T; Jacobi HH; Jing C; Reimert CM; Quan S; Dissing S; Poulsen LK; Skov PS
J Allergy Clin Immunol; 2000 Aug; 106(2):313-20. PubMed ID: 10932076
[TBL] [Abstract][Full Text] [Related]
13. Human coronary microvascular effects of cardioplegia-induced stromal-derived factor-1alpha.
Mieno S; Boodhwani M; Ramlawi B; Li J; Feng J; Bianchi C; Laham RJ; Li J; Sellke FW
Ann Thorac Surg; 2006 Aug; 82(2):657-63. PubMed ID: 16863781
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
Porcile C; Bajetto A; Barbieri F; Barbero S; Bonavia R; Biglieri M; Pirani P; Florio T; Schettini G
Exp Cell Res; 2005 Aug; 308(2):241-53. PubMed ID: 15921680
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.
Huang YC; Hsiao YC; Chen YJ; Wei YY; Lai TH; Tang CH
Biochem Pharmacol; 2007 Dec; 74(12):1702-12. PubMed ID: 17904532
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis.
Dutt P; Wang JF; Groopman JE
J Immunol; 1998 Oct; 161(7):3652-8. PubMed ID: 9759889
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
Shin HN; Moon HH; Ku JL
Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
